Organovo Holdings Inc
VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with … Read more
Market Cap & Net Worth: Organovo Holdings Inc (ONVO)
Organovo Holdings Inc (NASDAQ:ONVO) has a market capitalization of $3.37 Million ($3.37 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #33692 globally and #10996 in its home market, demonstrating a 12.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Organovo Holdings Inc's stock price $1.87 by its total outstanding shares 1800000 (1.80 Million).
Organovo Holdings Inc Market Cap History: 2015 to 2025
Organovo Holdings Inc's market capitalization history from 2015 to 2025. Data shows change from $89.64 Million to $3.37 Million (-31.09% CAGR).
Index Memberships
Organovo Holdings Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.20 Trillion | 0.00% | #850 of 976 |
|
NASDAQ Composite
IXIC
|
$32.97 Trillion | 0.00% | #2681 of 3165 |
Weight: Organovo Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Organovo Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Organovo Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
7.59x
Organovo Holdings Inc's market cap is 7.59 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $89.64 Million | $571.00K | -$30.08 Million | 156.99x | N/A |
| 2016 | $122.04 Million | $1.48 Million | -$38.58 Million | 82.29x | N/A |
| 2017 | $48.24 Million | $4.23 Million | -$38.45 Million | 11.40x | N/A |
| 2018 | $34.46 Million | $4.60 Million | -$34.80 Million | 7.49x | N/A |
| 2019 | $12.81 Million | $3.09 Million | -$26.64 Million | 4.14x | N/A |
| 2020 | $22.14 Million | $2.20 Million | -$18.71 Million | 10.08x | N/A |
| 2022 | $2.54 Million | $1.50 Million | -$11.45 Million | 1.69x | N/A |
| 2023 | $2.00 Million | $370.00K | -$17.26 Million | 5.40x | N/A |
| 2024 | $827.82K | $109.00K | -$14.67 Million | 7.59x | N/A |
Competitor Companies of ONVO by Market Capitalization
Companies near Organovo Holdings Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Organovo Holdings Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Organovo Holdings Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Organovo Holdings Inc's market cap moved from $89.64 Million to $ 3.37 Million, with a yearly change of -31.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.37 Million | +306.61% |
| 2024 | $827.82K | -58.57% |
| 2023 | $2.00 Million | -21.28% |
| 2022 | $2.54 Million | -61.16% |
| 2021 | $6.53 Million | -70.49% |
| 2020 | $22.14 Million | +72.90% |
| 2019 | $12.81 Million | -62.84% |
| 2018 | $34.46 Million | -28.57% |
| 2017 | $48.24 Million | -60.47% |
| 2016 | $122.04 Million | +36.14% |
| 2015 | $89.64 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Organovo Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.37 Million USD |
| MoneyControl | $3.37 Million USD |
| MarketWatch | $3.37 Million USD |
| marketcap.company | $3.37 Million USD |
| Reuters | $3.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.